Lineage Cell Therapeutics
LCTX
#8221
Rank
โ‚น13.58 B
Marketcap
โ‚น71.92
Share price
1.22%
Change (1 day)
-32.48%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น3.02 B

According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are โ‚น3.02 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น3.24 B-24.16%
2022-12-31โ‚น4.28 B-31.25%
2021-12-31โ‚น6.22 B563.94%
2020-12-31โ‚น0.93 B-7.6%
2019-12-31โ‚น1.01 B54.17%
2018-12-31โ‚น0.65 B14.83%
2017-12-31โ‚น0.57 B-30.07%
2016-12-31โ‚น0.81 B-32.27%
2015-12-31โ‚น1.21 B56.82%
2014-12-31โ‚น0.77 B-19.23%
2013-12-31โ‚น0.95 B219.98%
2012-12-31โ‚น0.29 B29.14%
2011-12-31โ‚น0.23 B34.15%
2010-12-31โ‚น0.17 B55.7%
2009-12-31โ‚น0.11 B-57.2%
2008-12-31โ‚น0.25 B104.62%
2007-12-31โ‚น0.12 B13.47%
2006-12-31โ‚น0.11 B14.88%
2005-12-31โ‚น96.99 M90.31%
2004-12-31โ‚น50.96 M-68.04%
2003-12-31โ‚น0.15 B24.66%
2002-12-31โ‚น0.12 B29.91%
2001-12-31โ‚น98.45 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น2.22 B-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA